重度异型增生痣是否需再切除:长期结局分析
该回顾性单中心研究纳入451例活检为重度异型增生痣的成人患者,随访至少5年,发现36.6%接受了再切除,再切除标本中诊断2例黑色素瘤,7例后续发生转移性黑色素瘤且均有黑色素瘤史,边缘注释影响再切除决策,结论认为并非所有重度异型增生痣都需再切除。
要点
- 重度异型增生痣再切除标本中仅2例诊断为黑色素瘤。
- 后续转移性黑色素瘤仅见于有黑色素瘤史的患者。
- 边缘注释影响再切除决策,并非所有重度异型增生痣都需再切除。
核心结论
- 重度异型增生痣可能不必全部进行再切除。
主要发现
- 451例重度异型增生痣患者中36.6%接受了再切除。
- 再切除标本中诊断2例黑色素瘤。
- 7例患者后续发生转移性黑色素瘤,均有黑色素瘤史。
- 边缘注释影响再切除决策。
临床怎么用
- 对于重度异型增生痣,可结合边缘注释及患者黑色素瘤史个体化决定是否再切除。
局限性
- 回顾性单中心研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dysplastic nevi with severe atypia (severely dysplastic nevi [SDN]) are frequently re-excised because of the concern that these lesions may in fact represent early melanoma. Data on long-term follow-up of these patients are limited. OBJECTIVE: We sought to determine the rate of subsequent melanoma development in patients with SDN who underwent re-excision versus those who did not and to determine factors associated with decision to re-excise. METHODS: A retrospective single institutional study was conducted with 451 adult patients (mean age 41.3 years) with SDN biopsied between November 1994 and November 2004, with clinical follow-up of at least 5 years. RESULTS: In 451 patients with SDN, re-excision was performed on 36.6%. Two melanomas were diagnosed in the re-excision specimens. Subsequent metastatic melanoma developed in 7 patients, all of whom had a history of melanoma. Margin comments influenced decision to re-excise. LIMITATIONS: This was a retrospective study at a single institution. CONCLUSION: Re-excision of all SDN may not be necessary.
引用
- Engeln K, Peters K, Ho J, et al. Dysplastic nevi with severe atypia: Long-term outcomes in patients with and without re-excision. J Am Acad Dermatol. 2016. PMID: 27838051. doi:10.1016/j.jaad.2016.08.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。